IQVIA Holdings | IQV - Ebitda

Stock Price
169.12
Daily Change
-1.56 -0.91%
Monthly
-1.65%
Yearly
18.41%
Q2 Forecast
165.72

IQVIA Holdings reported $932M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Accenture USD 4.35B 897.45M Dec/2025
Agilent USD 540M 74M Sep/2025
Bruker USD 110M 101.6M Mar/2026
Cardinal Health USD 1.09B 109M Mar/2026
Celltrion KRW 17.79B 356.77B Dec/2025
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cigna USD 2.86B 56M Mar/2025
Cognizant Technology Solutions USD 984M 9M Mar/2026
Computer Programs Systems USD 19.2M 10.52M Dec/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
CVS Health USD 5.83B 2.08B Mar/2026
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 8.9B 20M Dec/2025
Elevance Health USD 4.21B 2.02B Mar/2026
Humana USD 2.06B 2.35B Mar/2026
IBM USD 4B 2.5B Mar/2026
Illumina USD 469M 137M Dec/2025
Infosys INR 111.67B 16.57B Mar/2026
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Laboratory Of America USD 605.6M 17.5M Mar/2026
Malin Corporation EUR -1.1M 200K Dec/2024
McKesson USD 1.88B 206M Dec/2025
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Organigram Holdings CAD 5.26M 884K Dec/2025
Pharma Mar EUR 2.71M 42.25M Mar/2026
Publicis EUR 1.68B 190M Dec/2025
Qiagen NV USD 249.69M 56.53M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Sartorius EUR 267.3M 10.1M Mar/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Tilray USD 8.36M 1.82M Sep/2025
UnitedHealth USD 9.99B 8.5B Mar/2026
Veeva Systems USD 374.79M 3.96M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 380.97M 85.83M Dec/2025
Zealand Pharma A/S -727.47M 285.54M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026